Consistent with our data, Li et al (18) reported that immunoreactivity score of the activated AKT was very low (0–3) in >80% of cirrhotic and normal tissues, while it was high (4–6) in 65% of HCC patient tissues. Here, AKT1 is linked to hepatocellular carcinoma.